Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Donate your vehicle during the month of April or May and you'll be entered into a $500 Visa gift card drawing!

N.H.'s Drug Treatment Providers Report Financial Turmoil Due To Coronavirus Pandemic

Narcan, also known as naloxone, is an anti-overdose drug.
Paige Sutherland for NHPR

A new survey shows that income for substance use treatment and recovery providers in the state has decreased during the COVID-19 pandemic.

The survey, by the New Hampshire non-profit New Futures, received responses from 23 organizations that provide substance use treatment about how COVID has affected revenue, costs and staff.

Get updates about coronavirus in N.H. - sign up for our newsletter today

About 80 percent of survey respondents said they saw an overall decrease in revenue since March, with a decrease in Medicaid billing accounting for nearly all the total decrease from insurance billed revenue.

Most respondents to the survey said that they’ve been unable to hire staff during this time, and several had to lay off employees.

New Futures is asking the governor’s office handling coronavirus relief money to allocate between $15 million and $18 million for treatment centers in the state.

The non-profit says this would cover lost billed income and reimbursement costs for technology and PPE.

Daniela is an editor in NHPR's newsroom. She leads NHPR's Spanish language news initiative, ¿Qué Hay de Nuevo, New Hampshire? and the station's climate change reporting project, By Degrees. You can email her at dallee@nhpr.org.
Related Content

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.